🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.

Experimental Drug Acquiring Traction Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are urged to contact these accounts directly for supplier links, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a flourishing market exists on Telegram, where communities with numerous of participants share “before and after” images, injection guides and claims of rapid British shipping. Sellers promote the drug there before directing customers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could result in users injecting products of uncertain source.

Several professionals said the demand for retatrutide could be linked to the rising cost of licensed weight loss products such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate medicines, marketing, and customer regulations, risking penalties, prosecution or imprisonment.

Service Response and Content Elimination

According to TikTok, the service has removed problematic material and prohibited associated keywords and query recommendations. The company stated it was committed to keeping the service safe and allocating resources in enhancing enforcement strategies.

Online Trading Operations

Investigations also found groups with up to nine thousand members marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately brings up channels with numerous of users, populated with photos of slimming results, positive reviews and step-by-step instructions for preparing or administering at residence.

After moments of joining one community, a vendor posted WhatsApp details, where the majority of purchases take place. The seller provided an instruction manual and promised shipping within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about weight, medical conditions or previous experience.

Item Details and Pricing

Inside these communities, messages display black plastic parcels with postal service labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use pens usually sold at £160 for 20 milligrams. When asked how much time a injector should last, sellers give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for the messaging service said it actively monitored dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering substances they can’t verify. Although the science behind retatrutide is valid, these online products may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in demand to recent cost increases for approved slimming medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.

Her team has previously encountered individuals injured by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose users to possibly serious medical dangers”.